SCHEMBL8931989

SCHEMBL8931989

CC(=O)On1cnc2cc(-c3ccccc3C#N)ccc21

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 3/20 0.48
GABRG2 P18507 3/20 0.48
GABRB3 P28472 3/20 0.48
GABRA5 P31644 2/20 0.48
GABRA3 P34903 2/20 0.48
CYP1A2 P05177 6/20 0.42
CYP3A4 P08684 6/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 4/20 0.42
CLK4 Q9HAZ1 3/20 0.42
CYP2C19 P33261 2/20 0.42
ALOX15 P16050 1/20 0.42
ESR2 Q92731 1/20 0.42
HPGD P15428 3/20 0.41
MAPK1 P28482 2/20 0.41
HSD17B3 P37058 1/20 0.39
KDM4E B2RXH2 2/20 0.39
NR3C1 P04150 1/20 0.39
ABL1 P00519 1/20 0.39
PSEN1 P49768 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8931804 0.83 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7022829 0.76 GABRA1 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL4040299 0.74 NOTUM (0.37) ALDH1A1ESR2HPGDMAPK1KDM4E
SCHEMBL1884001 0.73 KMT2A (0.46) HSD17B10ALOX15KDM4EMEN1MAPT
SCHEMBL8931800 0.71 EGLN3 (0.46) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1761798 0.71 GABRA1 (0.69) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL7015212 0.70 GABRA1 (0.42) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1616723 0.67 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL1762276 0.65 GABRA1 (0.61) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL14992133 0.65 MAPK14 (0.50) CYP1A2CYP3A4ALDH1A1ESR2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5693633-A Angiotensin II antagonists ELI LILLY AND COMPANY (US) 1997-12-02 US disclosed